Navigation Links
Action of ghrelin hormone increases appetite and favors accumulation of abdominal fat
Date:5/20/2009

the metabolic syndrome, the researcher pointed out.

Ghrelin can show itself in acylated or deacylated form, the difference being in the octanoic acid present in the composition of the former, according to Ms Rodriguez. Previously it was thought that only the acylated form was active in the process of weight increase, but many studies point to both hormones being biologically functional.

Future development of pharmaceutical drugs

This discovery of the twin action of ghrelin on the organism opens the door to future treatment for obesity and which, for the time being, is limited to in vitro studies in cell and animal models, the University Hospital researcher pointed out. This inclusive perspective of the functioning of a hormone is necessary in order to design effective pharmaceutical drugs. There are many hormones that intervene in the control of appetite in the hypothalamus and, at the same time, can act on other organs, such as the liver, the muscles or fat, for example. Thus, the medication developed should block the action of ghrelin both on the hypothalamus and on the accumulation of abdominal fat.

At the same time, stated Ms Rodrguez, it has to be taken into account that this hormone also acts on the liver and favours the capturing of glucose in the muscle. They observed that the concentration of acylated-form ghreline in the blood increases amongst obese persons and particularly when these, moreover, suffer from diabetes. Thus, obese persons with diabetes have greater tendency to accumulate visceral fat than normoglycemic obese persons. This is a little-studied field which has to be investigated in order to develop pharmaceutical drugs which annul this action of ghrelin.

Blood analysis and stimulation of adipocytes

The research undertaken at the Metabolic Research Laboratory of the University Hospital of Navarra principally involved the analysis of the blood of 80 patients, both obese and
'/>"/>

Contact: Oihane Lakar
oihane@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Drug interactions with warfarin
2. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
3. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
4. First Circuit Court of Appeals Rules Against Philip Morris in Lights Class Action
5. AOA President Calls on Congress to Reauthorize SCHIP and Take Action to Ensure Health Care Coverage for All Americans
6. Kaiser Permanente Achieves Climate Action Leader Status
7. Loma Linda University Medical Center Selects Beryl to Manage Call Center Interactions for Womens Services Programs and Departments
8. Milestone Scientific Commences Declaratory Judgment Action With Respect to Its Single Tooth Anesthesia (STA(TM)) System and Compudent(TM) System
9. New Case Study Details How an Illinois Hospital Created a Safe Lifting Team that Dramatically Reduced Injuries, Increased Staff Satisfaction
10. J.D. Power and Associates Reports: CIGNA HealthCare Recognized for Call Center Customer Satisfaction Excellence For a Second Consecutive Year
11. Scientists reveal DNA-enzyme interaction with first ever real time footage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... June 19, 2013 Over the past ... Retailer industry has been growing at an annualized ... 2013. Many factors have supported the development of the ... retailed by drugstores; relatively higher drug prices in hospitals; ... government's support for the development of chain drug retailing ...
(Date:6/18/2013)... Chicago, IL (PRWEB) June 18, 2013 Exposed ... is helping thousands of acne suffers of all ages finally ... Unlike other acne treatment products, this new acne clearing system ... current acne, and prevent new acne from forming. ... , ExposedSkinCareReview.org believes these products are some of the most ...
(Date:6/18/2013)... Fla. (PRWEB) June 19, 2013 An ... When Linda Christina Beauregard was diagnosed with breast cancer, ... In her new book, “I Gave Myself Cancer, I ... Life” (published by Balboa Press), Beauregard explains how changing ... cancer. , "Sick people have been made to feel ...
(Date:6/18/2013)... Vienna, VA (PRWEB) June 18, 2013 As ... the increase in need for surgical equipment during childbirth comes ... the child from within the mother when she is unable ... difficult deliveries, they are associated with higher rates of complication ... addition to being harmful to the mother and child, forceps ...
(Date:6/18/2013)... Parker Waichman LLP , a ... victims injured by defective medical devices, reports that the ... bone graft products are now available. Published this week ... two studies serve up two key findings: There is ... and the traditional bone graft; and there is “substantial ...
Breaking Medicine News(10 mins):Health News:Pharmacies and Drug Retailers in China Industry Research Report – Now Available from IBISWorld 2Health News:Pharmacies and Drug Retailers in China Industry Research Report – Now Available from IBISWorld 3Health News:Exposed Skin Care Review Released by ExposedSkinCareReview.org 2Health News:Exposed Skin Care Review Released by ExposedSkinCareReview.org 3Health News:Cancer Survivor Linda Christina Beauregard Writes New Tell-All Book About Her Alternative Treatment Method 2Health News:Forceps Births Double, Obesity is Major Reason in Births Complications 2Health News:Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments 2Health News:Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments 3
... , DUQUESNE, Pa., Sept. 22 Wherever you live, ... house. From pulling out blankets, replacing smoke detector batteries, varying the ... their home routines in the fall. , , ... , If you are one of the estimated 40-50 ...
... INDIANAPOLIS, Sept. 22 Eli Lilly and Company (NYSE: ... Lilly China, has been promoted to president, Lilly USA, LLC. Ricks ... Business Unit as part of a company reorganization announced Sept. 14. , ... to lead Lilly USA, which is considered Lilly,s largest established market. , ...
... SALEM, N.H., Sept. 22 ALPCO is pleased ... easy and accurate measurement of both active (7-36) GLP-1 ... , , GLP-1, an incretin hormone, has been a focus ... was approved by the FDA in 2006, and early clinical data demonstrates that ...
... Results from Australia,s largest study of young drivers have shown ... roads. According to researchers from The George Institute, young drivers ... in serious crashes than those in urban areas. ... today at the launch of the Young Driver Factbase ...
... HATBORO, Pa., Sept. 22 InfoLogix, Inc. (Nasdaq: ... for the healthcare and commercial industries, announced today that it ... a private, not-for-profit healthcare system serving the greater Philadelphia area, ... large-scale Electronic Medical Record (EMR) implementation. , , ...
... , , DURHAM, N.C., Sept. 22 ... chairman and CEO, Chris Stern, will present at an investor conferences in ... will be at the Zurich Airport Radisson Hotel and is scheduled for ... be open to interested investors. , , ...
Cached Medicine News:Health News:'Flip for Fall' Seasonal Household Tips Include Ten Million Reasons to Use Allergy-Protective Bedding 2Health News:'Flip for Fall' Seasonal Household Tips Include Ten Million Reasons to Use Allergy-Protective Bedding 3Health News:Lilly Announces New U.S. Affiliate Leader 2Health News:ALPCO Launches GLP-1 (Active 7-36) and (7-36 and 9-36) ELISA Kits 2Health News:Rural roads dangerous for young drivers 2Health News:InfoLogix Selected by Albert Einstein Healthcare Network for eLearning Modules to Support EMR Implementation 2Health News:InfoLogix Selected by Albert Einstein Healthcare Network for eLearning Modules to Support EMR Implementation 3
(Date:6/18/2013)... HILL, N.C. , June 18, 2013  Recent ... more difficult for Medical Education groups at large pharmaceutical ... on the safe and effective use of their new ... the pharma industry, it is crucial that these ... reaching healthcare professionals. To address the changes ...
(Date:6/18/2013)... , June 18, 2013  Women are frequently ... but unfortunately they often do not give the same ... have kept information from their doctor because they were ... according to a recent survey conducted by Allergan and ... dedicated to bringing education, funding and research to the ...
(Date:6/18/2013)... The board of directors of Eli Lilly ... a dividend for the third quarter of 2013 of ... The dividend is payable September 10, 2013 to ... August 15, 2013. Lilly, a leading innovation-driven ... by applying the latest research from its own worldwide ...
Breaking Medicine Technology:Though Vital to Educating Doctors on New Products, Pharma "Med Ed" Groups Working Under Huge Internal & External Constraints 2New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 2New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 3New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 4New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 5New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 6New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 7New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 8New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 9
... RATE- MEDIAN SURVIVAL OF 10.5 MONTHS IN COMPLETE ... MEETINGSOUTH SAN FRANCISCO, Calif., March 3 Hana ... new positive preliminary efficacy results from a planned ... trial evaluating Marqibo(R) (vincristine sulfate liposomes injection) for ...
... Society of Gynecologic Oncologists (SGO) and the American College ... breast disease fellowship training program for gynecologic oncologists. ... program provides support for a gynecologic oncologist to complete ... of breast cancer and related disease. "As experts ...
Cached Medicine Technology:Hana Biosciences Announces New Positive Interim Efficacy Results in Pivotal rALLy Clinical Trial of Marqibo in Acute Lymphoblastic Leukemia 2Hana Biosciences Announces New Positive Interim Efficacy Results in Pivotal rALLy Clinical Trial of Marqibo in Acute Lymphoblastic Leukemia 3Hana Biosciences Announces New Positive Interim Efficacy Results in Pivotal rALLy Clinical Trial of Marqibo in Acute Lymphoblastic Leukemia 4Hana Biosciences Announces New Positive Interim Efficacy Results in Pivotal rALLy Clinical Trial of Marqibo in Acute Lymphoblastic Leukemia 5SGO and ACOG Announce Breast Cancer Fellowship Program for Gynecologic Oncologists 2SGO and ACOG Announce Breast Cancer Fellowship Program for Gynecologic Oncologists 3
Tendril DX active-fixation leads allows for lower thresholds initially and during the lead maturation phase....
... Guidant Flextend lead is ... lead with an extendable/retractable ... helix design offers various ... permanent implantation in the ...
... PY series leads are implantable bipolar ... stimulation of either the atrium or ... screw can be extended or retracted ... lead tip contains an anti-chattering mechanism ...
Used with permanent pacing leads....
Medicine Products: